Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Botulinum toxin: Drug formulations

Jonathan M Zand, PharmD BCPS
Section Editor
Jeffrey S Dover, MD, FRCPC
Deputy Editor
Abena O Ofori, MD

Botulinum toxin (BoNT) products used for improving cosmetic defects caused by muscle contraction and in the management of achalasia, dystonias, chronic migraine, spasticity, and other indications are commercially available as three serotype A preparations and one serotype B preparation. Links to the Lexicomp drug information topics are provided below.

For indications for clinical use and additional information on specific agents, refer to the relevant UpToDate topics.


Botulinum toxin type A: Lexicomp drug information monographs

AbobotulinumtoxinA (Dysport)

AbobotulinumtoxinA (botulinum toxin type A, Dysport): Drug information

AbobotulinumtoxinA (botulinum toxin type A, Dysport): Patient drug information


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Jan 15, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.